Critical roles of AMP-activated protein kinase in the carcinogenic metal-induced expression of VEGF and HIF-1 proteins in DU145 prostate carcinoma

Biochemical Pharmacology

Volumn 72, Issue 1, 2006, Pages 91-103

  Lee, Minyoung ^a   Hwang, Jin Taek ^a   Yun, Hee ^a   Kim, Eun Ju ^a   Kim, Min Jung ^a   Kim, Sung Soo ^a   Ha, Joohun ^a  

^a Kyung Hee University Hospital   (South Korea)

Author keywords

AMP activated protein kinase; Carcinogenic metals; Hypoxia inducibale factor 1; Prostate carcinoma; Reactive oxygen species; Vascular endothelial growth factor

Indexed keywords

ARSENIC TRIOXIDE; CARCINOGEN; COBALT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; HYPOXIA INDUCIBLE FACTOR 1; MESSENGER RNA; REACTIVE OXYGEN METABOLITE; VANADIC ACID; VASCULOTROPIN;

ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ADENOVIRIDAE; ARSENATES; CARCINOGENS; CELL LINE, TUMOR; CELL SURVIVAL; COBALT; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE TRANSFER TECHNIQUES; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; MALE; METALS; MULTIENZYME COMPLEXES; PROSTATIC NEOPLASMS; PROTEIN-SERINE-THREONINE KINASES; REACTIVE OXYGEN SPECIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; VANADATES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33646930317     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2006.03.021     Document Type: Article

References (54)

1. Nelson N. Metal ion transporters and homeostasis. EMBO J 18 16 (1999) 4361-4371
2. Beyersmann D. Interactions in metal carcinogenicity. Toxicol Lett 72 1-3 (1994) 333-338
3. Desurmont M. Carcinogenic effect of metals. Sem Hop 59 2930 (1983) 2097-2099
4. Harris G.K., and Shi X. Signaling by carcinogenic metals and metal-induced reactive oxygen species. Mutat Res 533 1-2 (2003) 183-200
5. Nicholson B., and Theodorescu D. Angiogenesis and prostate cancer tumor growth. J Cell Biochem 91 1 (2004) 125-150
6. Mukhopadhyay D., and Datta K. Multiple regulatory pathways of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) expression in tumors. Semin Cancer Biol 14 2 (2004) 123-130
7. 2-dependent degradation domain via the ubiquitin- proteasome pathway. Proc Natl Acad Sci USA 95 14 (1998) 7987-7992
8. Semenza G.L. HIF-1 and mechanisms of hypoxia sensing. Curr Opin Cell Biol 13 2 (2001) 167-171
9. Huang L.E., and Bunn H.F. Hypoxia-inducible factor and its biomedical relevance. J Biol Chem 278 22 (2003) 19575-19578
10. 2 homeostasis by hypoxia-inducible factor 1. Annu Rev Cell Dev Biol 15 (1999) 551-578
11. Goldberg M.A., and Schneider T.J. Similarities between the oxygen-sensing mechanisms regulating the expression of vascular endothelial growth factor and erythropoietin. J Biol Chem 269 6 (1994) 4355-4359
12. Jiang B.H., Agani F., Passaniti A., and Semenza G.L. V-SRC induces expression of hypoxia-inducible factor 1 (HIF-1) and transcription of genes encoding vascular endothelial growth factor and enolase 1: involvement of HIF-1 in tumor progression. Cancer Res 57 23 (1997) 5328-5335
13. Zelzer E., Levy Y., Kahana C., Shilo B.Z., Rubinstein M., and Cohen B. Insulin induces transcription of target genes through the hypoxia-inducible factor HIF-1alpha/ARNT. EMBO J 17 17 (1998) 5085-5094
14. Kimura H., Weisz A., Kurashima Y., Hashimoto K., Ogura T., D'Acquisto F., et al. Hypoxia response element of the human vascular endothelial growth factor gene mediates transcriptional regulation by nitric oxide: control of hypoxia-inducible factor-1 activity by nitric oxide. Blood 95 1 (2000) 189-197
15. Richard D.E., Berra E., and Pouyssegur J. Nonhypoxic pathway mediates the induction of hypoxia-inducible factor 1 alpha in vascular smooth muscle cells. J Biol Chem 275 35 (2000) 26765-26771
16. Tacchini L., Dansi P., Matteucci E., and Desiderio M.A. Hepatocyte growth factor signalling stimulates hypoxia inducible factor-1 (HIF-1) activity in HepG2 hepatoma cells. Carcinogenesis 22 9 (2001) 1363-1371
17. Hardie D.G., and Hawley S.A. AMP-activated protein kinase: the energy charge hypothesis revisited. Bioessays 23 12 (2001) 1112-1119
18. Carling D. The AMP-activated protein kinase cascade--a unifying system for energy control. Trends Biochem Sci 29 1 (2004) 18-24
19. Lee M., Hwang J.T., Lee H.J., Jung S.N., Kang I., Chi S.G., et al. AMP- activated protein kinase activity is critical for hypoxia-inducible factor-1 transcriptional activity and its target gene expression under hypoxic conditions in DU145 cells. J Biol Chem 278 41 (2003) 39653-39661
20. Yun H., Lee M., Kim S.S., and Ha J. Glucose deprivation increases mRNA stability of vascular endothelial growth factor through activation of AMP-activated protein kinase in DU145 prostate carcinoma. J Biol Chem 280 11 (2005) 9963-9972
21. Liu X.H., Kirschenbaum A., Yao S., Stearns M.E., Holland J.F., Claffey K., et al. Upregulation of vascular endothelial growth factor by cobalt chloride-simulated hypoxia is mediated by persistent induction of cyclooxygenase-2 in a metastatic human prostate cancer cell line. Clin Exp Metastasis 17 8 (1999) 687-694
22. Chachami G., Simos G., Hatziefthimiou A., Bonanou S., Molyvdas P.-A., and Paraskeva E. Cobalt induces hypoxia-inducible factor-1 {alpha} expression in airway smooth muscle cells by a reactive oxygen species- and PI3K- dependent mechanism. Am J Respir Cell Mol Biol 31 5 (2004) 544-551
23. Gao N., Ding M., Zheng J.Z., Zhang Z., Leonard S.S., Liu K.J., et al. Vanadate-induced expression of hypoxia-inducible factor 1 alpha and vascular endothelial growth factor through phosphatidylinositol 3-kinase/Akt pathway and reactive oxygen species. J Biol Chem 277 35 (2002) 31963-31971
24. Duyndam M.C., Hulscher T.M., Fontijn D., Pinedo H.M., and Boven E. Induction of vascular endothelial growth factor expression and hypoxia-inducible factor 1alpha protein by the oxidative stressor arsenite. J Biol Chem 276 51 (2001) 48066-48076
25. Hwang J.T., Lee M., Jung S.N., Lee H.J., Kang I., Kim S.S., et al. AMP-activated protein kinase activity is required for vanadate-induced hypoxia-inducible factor 1alpha expression in DU145 cells. Carcinogenesis 25 12 (2004) 2497-2507
26. Duyndam M.C., Hulscher S.T., van der Wall E., Pinedo H.M., and Boven E. Evidence for a role of p38 kinase in hypoxia-inducible factor 1-independent induction of vascular endothelial growth factor expression by sodium arsenite. J Biol Chem 278 9 (2003) 6885-6895
27. Woods A., Azzout-Marniche D., Foretz M., Stein S.C., Lemarchand P., Ferre P., et al. Characterization of the role of AMP-activated protein kinase in the regulation of glucose-activated gene expression using constitutively active and dominant negative forms of the kinase. Mol Cell Biol 20 18 (2000) 6704-6711
28. 3) in the orthotopic metastasis model of androgen-independent prostate cancer. Cancer Res 61 14 (2001) 5432-5440
29. Hardie D.G., Carling D., and Carlson M. The AMP-activated/SNF1 protein kinase subfamily: metabolic sensors of the eukaryotic cell?. Annu Rev Biochem 67 (1998) 821-855
30. De Boeck M., Kirsch-Volders M., and Lison D. Cobalt and antimony: genotoxicity and carcinogenicity. Mutat Res 533 1-2 (2003) 135-152
31. 2 in rat heart endothelial cells. Free Radic Biol Med 25 8 (1998) 891-897
32. Kuroki M., Voest E.E., Amano S., Beerepoot L.V., Takashima S., Tolentino M., et al. Reactive oxygen intermediates increase vascular endothelial growth factor expression in vitro and in vivo. J Clin Invest 98 7 (1996) 1667-1675
33. Choi S.L., Kim S.J., Lee K.T., Kim J., Mu J., Birnbaum M.J., et al. The regulation of AMP-activated protein kinase by H(2)O(2). Biochem Biophys Res Commun 287 1 (2001) 92-97
34. Zhou G., Myers R., Li Y., Chen Y., Shen X., Fenyk-Melody J., et al. Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest 108 8 (2001) 1167-1174
35. Gao N., Jiang B.H., Leonard S.S., Corum L., Zhang Z., Roberts J.R., et al. p38 Signaling-mediated hypoxia- inducible factor 1 alpha and vascular endothelial growth factor induction by Cr(VI) in DU145 human prostate carcinoma cells. J Biol Chem 277 47 (2002) 45041-45048
36. Pourahmad J., O'Brien P.J., Jokar F., and Daraei B. Carcinogenic metal induced sites of reactive oxygen species formation in hepatocytes. Toxicol In Vitro 17 5-6 (2003) 803-810
37. Boffetta P. Carcinogenicity of trace elements with reference to evaluations made by the International Agency for Research on Cancer. Scand J Work Environ Health 19 Suppl. 1 (1993) 67-70
38. Li Q., Chen H., Huang X., and Costa M. Effects of 12 metal ions on iron regulatory protein 1 (IRP-1) and hypoxia-inducible factor-1 alpha (HIF-1 alpha) and HIF-regulated genes. Toxicol Appl Pharmacol (2005)
39. 2, a chemical inducer of hypoxia-inducible factor-1, and hypoxia reduce apoptotic cell death in hepatoma cell line HepG2. Ann NY Acad Sci 973 (2002) 443-447
40. Laughner E., Taghavi P., Chiles K., Mahon P.C., and Semenza G.L. HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1 alpha (HIF-1 alpha) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression. Mol Cell Biol 21 12 (2001) 3995-4004
41. Gao N., Shen L., Zhang Z., Leonard S.S., He H., Zhang X.G., et al. Arsenite induces HIF-1 alpha and VEGF through PI3K, Akt and reactive oxygen species in DU145 human prostate carcinoma cells. Mol Cell Biochem 255 1-2 (2004) 33-45
42. Kallio P.J., Wilson W.J., O'Brien S., Makino Y., and Poellinger L. Regulation of the hypoxia-inducible transcription factor 1 alpha by the ubiquitin-proteasome pathway. J Biol Chem 274 10 (1999) 6519-6525
43. Sandau K.B., Zhou J., Kietzmann T., and Brune B. Regulation of the hypoxia- inducible factor 1 alpha by the inflammatory mediators nitric oxide and tumor necrosis factor-alpha in contrast to desferroxamine and phenylarsine oxide. J Biol Chem 276 43 (2001) 39805-39811
44. Chen F., and Shi X. Signaling from toxic metals to NF-kappaB and beyond: not just a matter of reactive oxygen species. Environ Health Perspect 110 Suppl. 5 (2002) 807-811
45. 2 sensing. J Biol Chem 275 33 (2000) 25130-25138
46. Salnikow K., Su W., Blagosklonny M.V., and Costa M. Carcinogenic metals induce hypoxia-inducible factor-stimulated transcription by reactive oxygen species-independent mechanism. Cancer Res 60 13 (2000) 3375-3378
47. Clyne N., Hofman-Bang C., Haga Y., Hatori N., Marklund S.L., Pehrsson S.K., et al. Chronic cobalt exposure affects antioxidants and ATP production in rat myocardium. Scand J Clin Lab Invest 61 8 (2001) 609-614
48. Patrick L. Toxic metals and antioxidants: Part II. The role of antioxidants in arsenic and cadmium toxicity. Altern Med Rev 8 2 (2003) 106-128
49. Davison K., Mann K.K., and Miller Jr. W.H. Arsenic trioxide: mechanisms of action. Semin Hematol 39 2 Suppl. 1 (2002) 3-7
50. Chen F., Vallyathan V., Castranova V., and Shi X. Cell apoptosis induced by carcinogenic metals. Mol Cell Biochem 222 1-2 (2001) 183-188
51. Bode A.M., and Dong Z. The paradox of arsenic: molecular mechanisms of cell transformation and chemotherapeutic effects. Crit Rev Oncol Hematol 42 1 (2002) 5-24
52. Chan P.C.H.J. Arsenic carcinogenesis in animals and in humans: mechanistic, experimental and epidemiological evidence. Environ Carcinog Ecotoxicol Rev C15 (1997) 83-122
53. Othumpangat S., Kashon M., and Joseph P. Sodium arsenite-induced inhibition of eukaryotic translation initiation factor 4E (eIF4E) results in cytotoxicity and cell death. Mol Cell Biochem 279 1-2 (2005) 123-131
54. Lazar-Molnar E., Hegyesi H., Toth S., and Falus A. Autocrine and paracrine regulation by cytokines and growth factors in melanoma. Cytokine 12 6 (2000) 547-554